Deutsch English Français

Contact

EP2705154

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2705154

EP2705154 - FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR MONITORING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE [Right-click to bookmark this link]
Status	The application has been refused Status updated on 24.02.2017 Database last updated on 16.11.2024
Most recent event Tooltip	24.02.2017	Refusal of application	published on 29.03.2017 [2017/13]
Applicant(s)	For all designated states TechLab, Inc. 2001 Kraft Drive Blacksburg, VA 24060-6358 / US
	[2014/11]
Inventor(s)	01 / BOONE, James, Hunter 545 Arrowhead Trail Christiansburg, VA 24073 / US
	02 / LYERLY, David, M. 204 Macarthur Avenue Radford, VA 24142 / US
	03 / WILKINS, Tracy, D. 6254 Chestnut Ridge Road Riner, VA 24149 / US
	04 / CARMAN, Robert, J. 1700 North Fork Road Christiansburg, VA / US
	[2014/11]
Representative(s)	Fyfe, Fiona Allison Watson Murgitroyd & Company Scotland House 165-169 Scotland Street Glasgow G5 8PL / GB
	[2014/11]
Application number, filing date	12777788.6	27.04.2012
	WO2012US35495
Priority number, date	US201161480616P	29.04.2011 Original published format: US 201161480616 P
	US201213457064	26.04.2012 Original published format: US201213457064
	US201213457049	26.04.2012 Original published format: US201213457049
	[2014/11]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2012149351
	Date:	01.11.2012
	Language:	EN
	[2012/44]
	Type:	A1 Application with search report
	No.:	EP2705154
	Date:	12.03.2014
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 01.11.2012 takes the place of the publication of the European patent application.
	[2014/11]
Search report(s)	International search report - published on:	US	01.11.2012
	(Supplementary) European search report - dispatched on:	EP	15.10.2014
Classification	IPC:	C12P21/04, A61K31/14, A61K31/4164, A61K31/7034, A61K35/74, G01N33/569, A61K38/14	[2014/46]
	CPC:	G01N33/56911 (EP,US); A61K31/4164 (EP,US); A61K31/7034 (EP,US); A61K35/74 (EP,US); A61K38/14 (EP,US); A61K45/06 (US); (+) A61P1/00 (EP); A61P1/12 (EP); A61P31/04 (EP); G01N2333/33 (EP,US); G01N2333/79 (EP,US); G01N2800/52 (EP,US); G01N2800/56 (EP,US) (-)
	Former IPC [2014/11]	C12P21/04, G01N33/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/11]
Extension states	BA	31.10.2013
	ME	31.10.2013
Title	German:	LACTOFERRIN AUS FÄKALIEN ALS BIOMARKER ZUR BESTIMMUNG DER SCHWERE EINER ERKRANKUNG UND ÜBERWACHUNG DER INFEKTION BEI PATIENTEN MIT CLOSTRIDIUM DIFFICILE ERKRANKUNG	[2014/11]
	English:	FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR MONITORING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE	[2014/11]
	French:	LACTOFERRINE FÉCALE EN TANT QUE BIOMARQUEUR POUR LA DÉTERMINATION DE LA SÉVÉRITÉ D'UNE MALADIE ET POUR LA SURVEILLANCE D'UNE INFECTION CHEZ DES PATIENTS ATTEINTS PAR UNE MALADIE PAR CLOSTRIDIUM DIFFICILE	[2014/11]
Entry into regional phase	31.10.2013	National basic fee paid
	31.10.2013	Search fee paid
	31.10.2013	Designation fee(s) paid
	31.10.2013	Examination fee paid
Examination procedure	31.10.2013	Examination requested [2014/11]
	29.04.2015	Amendment by applicant (claims and/or description)
	01.10.2015	Despatch of a communication from the examining division (Time limit: M04)
	10.02.2016	Reply to a communication from the examining division
	25.10.2016	Cancellation of oral proceeding that was planned for 16.11.2016
	14.11.2016	Despatch of communication that the application is refused, reason: substantive examination [2017/13]
	16.11.2016	Date of oral proceedings (cancelled)
	24.11.2016	Application refused, date of legal effect [2017/13]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.10.2015
Fees paid	Renewal fee
	28.04.2014	Renewal fee patent year 03
	27.04.2015	Renewal fee patent year 04
	27.04.2016	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]US2009253155 (BOONE JAMES HUNTER [US], et al)
		[X] - OPPENHEIM., "Scientific Symposium on New Approaches to Clostridium difficile Testing", (20101023), URL: http://www.alere.co.uk/pdf/150411101655-Alere_Barcelona_FINAL1.pdf, (20120706), XP055093104
		[Y] - "Guidelines for the Management of Clostridium difficile-Associated Disease (CDAD) in Adult Patients", NEW YORK-PRESBYTERIAN., (20080828), URL: http://www.id.hs.columbia.edu/documents/Guidelines-Clostridiumdifficile- 8-28-08.pdf, (20120706), XP055093109
		[Y] - SHASTRI ET AL., "Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea.", AM J MED DECEMBER, (2008), vol. 121, no. 12, pages 1099 - 1106, XP025686969 DOI: http://dx.doi.org/10.1016/j.amjmed.2008.06.034
		[Y] - YOON ET AL., "Treatment of Refractory/Recurrent C. difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy.", J CLIN GASTROENTEROL, (201009), vol. 44, no. 8, pages 562 - 566, XP008171466 DOI: http://dx.doi.org/10.1097/MCG.0b013e3181dac035
	by applicant	US2009253155
		- TED S STEINER ET AL., "Fecal Lactoferrin, Interleukin-1 beta, and Interleukin-8 Are Elevated in Patients with Severe Clostridium difficile Colitis", CLIN DIAGNOST LAB IMMUNOL, (19971101), vol. 4, no. 6, pages 719 - 722, XP055144433
		- SHASTRI ET AL., "Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea", AM J MED, (200812), vol. 121, no. 12, doi:doi:10.1016/j.amjmed.2008.06.034, pages 1099 - 1106, XP025686969 DOI: http://dx.doi.org/10.1016/j.amjmed.2008.06.034

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p